Prenatal Supplements Market and Competition Outlook 2026-2031 with 3 Months of Analyst Support
Dublin, Aug. 17, 2026 (GLOBE NEWSWIRE) -- The "Prenatal Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global prenatal supplements market was valued at USD 4.01 billion in 2025 and is expected to increase from USD 4.44 billion in 2026 to USD 7.51 billion by 2031. The market is projected to register a compound annual growth rate of 11.07% during the 2026-2031 forecast period, supported by stronger clinical recommendations, rising maternal health awareness, delayed pregnancies, and continued innovation in prenatal nutrition.
Medical Recommendations Support Prenatal Supplement Demand
Healthcare professionals are increasingly positioning prenatal supplements as an integral component of maternal care. The National Institutes of Health recommends that women who are pregnant or may become pregnant consume 400-800 micrograms of folic acid daily, with intake requirements rising during pregnancy. Consistent guidance from medical organizations is strengthening consumer confidence and encouraging broader adoption of prenatal vitamins and minerals.
Industry and healthcare stakeholders are also working to address product safety concerns and reinforce evidence-based communication. These efforts are expected to support trust in established prenatal supplement brands while increasing demand for clinically supported formulations.
Advanced Maternal Age Drives Product Innovation
The rising average maternal age, particularly in developed markets, is increasing demand for specialized prenatal nutrition products. Pregnancies among women aged 35 and older often receive greater clinical monitoring, creating opportunities for comprehensive formulations designed around specific micronutrient requirements.
Research cited by organizations including the World Health Organization indicates that multiple micronutrient supplementation can help reduce adverse outcomes such as low birth weight and preterm birth, particularly in higher-risk pregnancies. Manufacturers are responding with premium products that incorporate targeted nutrient combinations and support age-specific maternal health needs.
Premium Product Costs Remain a Market Restraint
Affordability continues to limit the adoption of advanced prenatal supplements, especially in developing economies and among lower-income consumers. Products containing specialized folate, DHA, probiotics, organic ingredients, or patented delivery systems can cost substantially more than standard prenatal vitamins.
Limited insurance coverage further increases out-of-pocket expenses. Although some healthcare plans cover basic prenatal vitamins, premium formulations are frequently excluded. Wider insurance coverage, public health subsidies, and more accessible pricing strategies could help manufacturers expand their consumer base.
Segment Insights
Vitamins and minerals accounted for 63.58% of the prenatal supplements market in 2025. The segment benefits from established clinical guidance supporting folic acid, iron, and calcium intake during pregnancy. Product development is increasingly focused on bioavailability, targeted delivery, L-5-MTHF, and choline-enriched folate formulations.
Essential fatty acids are projected to be the fastest-growing product segment, registering a 15.88% CAGR from 2026 to 2031. Growth is being driven by scientific evidence connecting omega-3 fatty acids, particularly DHA, with fetal brain and eye development. Probiotics, enzymes, and specialty nutrients are also gaining attention as research into maternal nutrition and the microbiome advances.
Digital marketing campaigns, expanding online retail availability, and rising interest in natural, organic, and plant-based prenatal supplements are creating additional growth opportunities. However, counterfeit products and inconsistent quality controls remain concerns for consumers, regulators, and established manufacturers.
Regional Prenatal Supplements Market Outlook
North America held a 30.86% market share in 2025, supported by high health awareness, established healthcare infrastructure, medical endorsements, and demand for personalized nutrition. Regulatory attention to ingredient quality, heavy metals, and labeling transparency is expected to influence product development and manufacturing standards.
Asia-Pacific is projected to record an 8.96% CAGR between 2026 and 2031. Rising disposable incomes, maternal health initiatives, and greater nutritional awareness are supporting regional expansion. Indonesia's transition from iron and folic acid supplementation to multiple micronutrient supplements for pregnant women illustrates the growing role of public health programs in market development.
Europe remains an important prenatal supplements market, shaped by strict requirements for health claims, ingredient safety, sourcing transparency, and sustainability. South America and the Middle East and Africa are also expanding as governments, healthcare organizations, and commercial suppliers increase their focus on maternal nutrition.
Report Scope and Competitive Landscape
The prenatal supplements market report segments the industry by type, including vitamins and minerals, essential fatty acids, and other products. Forms covered include capsules and softgels, tablets, gummies, powders, and additional formats. Distribution channels include supermarkets and hypermarkets, specialty and health stores, online retailers, and other channels. Geographic coverage includes North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with market forecasts provided in USD value terms.
Companies covered include Bayer AG, Church & Dwight Co., Inc., Abbott Laboratories, Reckitt Benckiser Group plc, Otsuka Holdings Co., Ltd., Nestle S.A., Pharmavite LLC, Nordic Naturals, Inc., Thorne HealthTech Inc., NOW Foods, Perrigo Company plc, Vitabiotics Ltd., Pharma Nord, MegaFood, Perelel, Pink Stork, and other established and emerging prenatal supplement manufacturers.
The report also includes a market estimate sheet in Excel format and three months of analyst support.
Key Topics Covered
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESERACH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Medical Community Support Strengthening Market Position
4.2.2 Advanced Maternal Age Intensifying Focus on Fetal Development
4.2.3 Digital Marketing Campaigns Expanding Market Reach
4.2.4 Increased Preference for Natural, Organic, And Plant-Based Prenatal Supplements.
4.2.5 Government and NGO Initiatives Promoting Maternal Health
4.2.6 Advancements in Supplement Formulations Improving Efficacy
4.3 Market Restraints
4.3.1 High Cost of Premium Prenatal Supplements Limiting Affordability
4.3.2 Presence of Counterfeit Products Undermining Consumer Trust
4.3.3 Potential Side Effects Like Nausea and Constipation Deterring Usage
4.3.4 Lack of Standardized Regulations Causing Quality Inconsistencies
4.4 Consumer Behavior Analysis
4.5 Regulatory Outlook
4.6 Porter's Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS
5.1 By Type
5.1.1 Vitamins and Minerals
5.1.2 Essential Fatty Acids
5.1.3 Others
5.2 By Form
5.2.1 Capsules and Softgels
5.2.2 Tablets
5.2.3 Gummies
5.2.4 Powders
5.2.5 Others
5.3 By Distribution Channel
5.3.1 Supermarkets/Hypermarkets
5.3.2 Specialty and Health Stores
5.3.3 Online Retailers
5.3.4 Other Distribution Channels
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Spain
5.4.2.5 Italy
5.4.2.6 Netherlands
5.4.2.7 Sweden
5.4.2.8 Poland
5.4.2.9 Belgium
5.4.2.10 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 South Korea
5.4.3.5 Australia
5.4.3.6 Indonesia
5.4.3.7 Thailand
5.4.3.8 Singapore
5.4.3.9 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Chile
5.4.4.4 Columbia
5.4.4.5 Peru
5.4.4.6 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 South Africa
5.4.5.2 Saudi Arabia
5.4.5.3 United Arab Emirates
5.4.5.4 Nigeria
5.4.5.5 Egypt
5.4.5.6 Morocco
5.4.5.7 Turkey
5.4.5.8 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Ranking
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Bayer AG
6.4.2 Church & Dwight Co., Inc.
6.4.3 Abbott Laboratories
6.4.4 Reckitt Benckiser Group plc
6.4.5 Otsuka Holdings Co., Ltd.
6.4.6 Nestle S.A.
6.4.7 Piping Rock Health Products, LLC
6.4.8 Sundance Vitamins
6.4.9 Pharmavite LLC
6.4.10 Nordic Naturals, Inc.
6.4.11 Rainbow Light Nutritional Systems
6.4.12 Perelel
6.4.13 Country Life LLC
6.4.14 MegaFood (FoodState Inc.)
6.4.15 SilverOnyx, LLC
6.4.16 MamaBird (Best Nest Wellness)
6.4.17 Thorne HealthTech Inc.
6.4.18 NOW Foods
6.4.19 Perrigo Company plc
6.4.20 Vitabiotics Ltd.
6.4.21 Pharma Nord
6.4.22 Maxi Health Research LLC
6.4.23 Pink Stork
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
For more information about this report visit https://www.researchandmarkets.com/r/vf6f13
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.